SANION Saniona AB (publ)
9.300SEK-3.02%Mkt Cap: 122.79M $P/E: 7.21Today
Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…
Industry Peers
Biotechnology$127.24BUSDP/E 29.3
$76.05BUSDP/E 18.3
$74.84BUSD
$56.77BUSDP/E 37.1
$58.21BUSDP/E 35.5
$41.93BUSDP/E 17.9
$42.84BUSD
$41.27BUSDP/E 64.9
$32.61BUSDP/E 30.0
$29.97BUSDP/E 37.8
$25.66BUSD
$24.05BUSD
$23.24BUSDP/E 29.8
$22.98BUSD
$22.23BUSDP/E 30.6
$22.85BUSDP/E 14.4
$15.02BUSDP/E 15.9
$14.87BUSDP/E 17.3
$14.45BUSDP/E 18.4
$13.81BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Saniona AB (LTS:0RQJ) (Q2 2026) Earnings Call Highlights: Strategic Pipeline Prioritization ... Saniona AB (LTS:0RQJ) narrows focus to SAN2668 and SAN2465, reporting a SEK58 million net loss while securing non-dilutive funding and advancing toward key clinical milestones. | ||
BBiostock | ||